Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MARK4 inhibitor 1

Copy Product Info
😃Good
Catalog No. T11947Cas No. 2271081-58-2

MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis. MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.

MARK4 inhibitor 1

MARK4 inhibitor 1

Copy Product Info
😃Good
Purity: 97.7%
Catalog No. T11947Cas No. 2271081-58-2
MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis. MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$115In StockIn Stock
5 mg$272In StockIn Stock
10 mg$396In StockIn Stock
25 mg$665In StockIn Stock
50 mg$947In StockIn Stock
100 mg$1,280In StockIn Stock
200 mg$1,720-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.7%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

MARK4 inhibitor 1 AI Summary
MARK4 inhibitor 1 exhibits a range of bioactivities that highlight its potential as an anticancer agent. It demonstrates inhibition of human recombinant MARK4 activity with an IC50 value of 1540 nM and shows a strong binding affinity to human recombinant MARK4 with a Ka value of 6.0 x 10^7/M. Additionally, it binds to human serum albumin (HSA) with a Ka value of 1.27 x 10^4/M. The compound has notable antiproliferative effects against various cancer cell lines including MCF7, MDA-MB-435S, HepG2, and HEK293, with IC50 values ranging from 6220 nM to 200000 nM. It induces apoptosis in these cell lines, as evidenced by flow cytometric analysis using Annexin V-FITC/propidium iodide staining. MARK4 inhibitor 1 also inhibits the growth of several cancer cell lines at a concentration of 10 µM after 48 hours, showing variable inhibition percentages relative to control cells. Overall, MARK4 inhibitor 1 displays promising bioactivities by inhibiting cell growth, inducing apoptosis, and interacting with key molecular targets..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis. MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.
Targets&IC50
MARK4:1.54 μM
Chemical Properties
Molecular Weight390.4
FormulaC20H18N6O3
Cas No.2271081-58-2
SmilesCOc1ccc(Cn2cc(nn2)C(=O)N\N=C2\C(=O)Nc3c2cccc3C)cc1
Relative Density.1.42 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: Slightly soluble

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MARK4 inhibitor 1 | purchase MARK4 inhibitor 1 | MARK4 inhibitor 1 cost | order MARK4 inhibitor 1 | MARK4 inhibitor 1 chemical structure | MARK4 inhibitor 1 formula | MARK4 inhibitor 1 molecular weight